Conversion: SI to traditional units-Bilirubin: 1 jsmol/l sw58-47 pg/100 ml.
positive at 12 months, at which time all of them were also found to be HBeAg positive in serum; liver biopsy specimens were taken in two cases, and both showed features of chronic active hepatitis. Two of the 9 patients subsequently died and three were lost to further follow up. All four patients that could be observed for up to two years remained HBsAg and HBeAg positive with fluctuating transaminase activities.
Of the four non-immunosuppressed children with evidence of continuing liver disease at 12 months, two were born to HBeAg positive mothers and the other two had presented with papular acrodermatitis. All four patients remained HBsAg and HBeAg positive and were asymptomatic throughout the observation period. Liver biopsy specimens taken during the second year of illness were consistent with chronic active hepatitis in three patients and with chronic lobular hepatits in the fourth.
Discussion
Acute symptomatic hepatitis B in our region is rarely observed in children,'0 unlike hepatitis A. The present data seem to indicate a trend toward a further reduction in the incidence of hepatitis B, coinciding with the reduction in the total number of cases of acute hepatitis in childhood, as also reported in other European countries." Increased alanine-9 (69%) 4 (9%) aminotransferase activity after 12 months In our patients, acute hepatitis B was seldom observed in children below one year of age and transmission of infection from mother to neonate occurred in only four children, who developed symptomatic illness within the fourth month of life. Indeed, acute hepatitis seems to be a rare clinical manifestation of infection transmitted in the neonatal period. Shiraki et al.'2 reported only three cases among 24 children who acquired infection from their HBsAg positive mothers and were born to anti-HBe positive or to HBeAg negative mothers. Our results not only confirm the possibility that children born to anti-HBe positive mothers may develop overt hepatitis but also indicate that the disease may be severe and, therefore, should be prevented.
In children with no underlying diseases, blood transfusions were found to play a minor epidemiological part and evidence of percutaneous exposure was also rare. In more than half of these patients, therefore, the source ofinfection remained undefined. Most of them, however, had probably acquired infection from contact with asymptomatic HBsAg carriers; infection with hepatitis B virus is endemic in Italy.
In the course of our survey a consistent number of children who developed HBsAg positive hepatitis had leukaemia or malignancy and were receiving immunosuppressive treatment. Routine testing for HBsAg had not been performed in these patients before the development of acute hepatitis, and we cannot, therefore, exclude the possibility that, in some cases at least, a reactivation of a latent infection may have occurred after withdrawal of immunosuppressive treatment. 
